The Investigational New Drug (IND) Workshop
This event has passed.
Tuesday, April 10, 2018 - 1:00pm to 4:00pm
Daniel Tonkin, PhD, RAC & Stephanie Pierce, PhD, RAC
Define an investigational drug, including off-label use of FDA approved drugs Provide guidance on determining when the IND regulations apply to research studies. Discuss the preparation and submission of IND applications to FDA Review maintenance and safety reporting requirements Encourage participant discussion of case scenarios